United States:
FDA Authorizes Emergency Use Of IV Diagnostics For Ebola Detection
18 February 2015
Jones Day
To print this article, all you need is to be registered or login on Mondaq.com.
In the February 9, 2015, Federal Register,
FDA issued three emergency use authorizations, one of which was
amended after initial issuance, for three in vitro diagnostic
devices for detection of the Ebola virus in response to the 2014
Ebola virus outbreak in West Africa.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
